The NIH Chemical Genomics Center
The NIH Chemical Genomics Center
Principal Investigator: Christopher Austin
The NIH Chemical Genomics Center (NCGC) is an ultrahigh-throughput screening and chemistry center that applies the tools of small molecule screening and discovery to develop chemical probes for the study of protein and cell functions. Using a process called quantitative high-throughput screening (qHTS), chemical libraries are screened at multiple concentrations (typically seven) to generate a concentration-response curve for each compound. qHTS comprehensively and efficiently characterizes biological activities of large chemical libraries to yield high quality datasets for chemical probe development and compound profiling. This process has been applied successfully to both cell-free and cell-based assays. Our Kalypsys robotic system uses multimodal detectors, the ViewLux and Envision systems, and a plate-based laser cytometry system, the Acumen Explorer, for high-capacity screening (100,000+ wells/day) in the reagent-sparing 1536-well plate format. The Center’s assay detection capabilities include absorbance, luminescence, FRET, TR-FRET, FP, FI, AlphaScreen�, as well as cell-based imaging assays that employ fluorescent proteins such as GFP. The NCGC also develops new paradigms for screening, informatics, and chemical probe development that extend the application of small molecule technology to new areas of the genome. The Center collaborates with pharmaceutical and biotechnology companies to produce public domain data, thereby allowing sharing of best practices to enable both chemical genomics and downstream drug development. The NCGC is also accepting chemical libraries from academic or industrial investigators, and encouraging library design and synthesis within the NCGC by visiting scientists. Using its qHTS process as little as 0.1 - 0.5 mg of compound will support several years of screening against numerous diverse biological systems. Libraries enter the NCGC archive for biological profiling as a 7-point titration covering a concentration range of nearly 5 orders of magnitude (typical concentrations in the biological assay begin at 100-30 uM and end at 3 to 1 nM). The NCGC is part of the intramural program of the National Human Genome Research Institute.
NCGC Capabilities and Technologies
| Assay Formats | Screening Capabilities | Biologicial Expertise |
|---|---|---|
| Absorbance | 1536-well compound titration-based primary screening | Enzyme assays (kinase, phosphatase, protease, etc.) |
| AlphaScreen | Biochemical Assay Screening | Receptor functional assays |
| Fluorescence | Cell-Based Assay Screening | Protein-protein interaction assays |
|
High-Content Cell-Based laser cytometry | Reconstituted enzyme cascades |
|
High Throughput Cell Imaging | Metabolic enzyme systems |
|
Redox enzyme systems | |
|
Assays relevant to rare genetic disorders | |
| Luminescence | Understudied genes and gene families | |
| Laser scanning cytometry (Acumen Explorer) | Cellular signaling pathways | |
| Microscopy-based imaging (INCell 1000) | GFP-based assays | |
| Epigenetic mechanisms | ||
| Compound profiling for ADMET and physiochemical properties | ||
| RNA splicing assay | ||
| Cell proliferation and cell death | ||
| Cytotoxicity assays |
For inquiries about assay development at a The NIH Chemical Genomics Center (NCGC), please contact the center representative listed in conjunction with visiting the Center’s Web site.
- The NIH Chemical Genomics Center
- Please contact: Christopher P. Austin, M.D. or his Assistant, Denise Philippi
See also: Enabling PI-Center Collaboration Document
For further information about The NIH Chemical Genomics Center, see below:



